Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson's (2023)
Attributed to:
JPND Alpha-synuclein pathology propagation in Parkinson's disease and quest for novel protective strategies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/ejn.16180
PubMed Identifier: 37941514
Publication URI: http://europepmc.org/abstract/MED/37941514
Type: Journal Article/Review
Parent Publication: European Journal of Neuroscience
ISSN: 0953-816X